Showing results (261-270 of 651) with videos related to
Sort By:
Pageof 66
Diagnostics (Basel, Switzerland)|August 27, 2021
Effect of Liraglutide on Vascular Inflammation Evaluated by [64Cu]DOTATATEEmilie H Zobel, Rasmus S Ripa, Bernt J von Scholten, et al.Frontiers in Endocrinology|December 17, 2021
Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [64Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME TrialJacob K Jensen, Emilie H Zobel, Bernt J von Scholten, et al.Cardiovascular Diabetology|December 20, 2025
Once-weekly semaglutide versus placebo for the treatment of type 2 diabetes and chronic kidney disease in Denmark: A long-term cost-effectiveness analysis based on FLOWPeter Rossing, Morten Lindhardt, Christian Klyver Tikkanen, et al.Diabetes|July 21, 2023
Ceramides as Risk Markers for Future Cardiovascular Events and All-Cause Mortality in Long-standing Type 1 DiabetesAsger Wretlind, Viktor R Curovic, Tommi Suvitaival, et al.BMJ Open Diabetes Research & Care|October 14, 2021
Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetesTheis Bjerre-Christensen, Signe A Winther, Nete Tofte, et al.Diabetes Care|January 29, 2011
Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up studyJohanna W Nin, Anders Jorsal, Isabel Ferreira, et al.Journal of the American Society of Nephrology : JASN|May 2, 2008
Urinary proteomics in diabetes and CKDKasper Rossing, Harald Mischak, Mohammed Dakna, et al.Cardiovascular Diabetology|September 24, 2016
Cholesterol remnants and triglycerides are associated with decreased myocardial function in patients with type 2 diabetesPeter Godsk Jørgensen, Magnus Thorsten Jensen, Tor Biering-Sørensen, et al.Plos One|April 27, 2018
Growth differentiation factor-15 and fibroblast growth factor-23 are associated with mortality in type 2 diabetes - An observational follow-up studyMarie Frimodt-Møller, Bernt Johan von Scholten, Henrik Reinhard, et al.Diabetes Care|September 12, 2022
Endotrophin as a Marker of Complications in a Type 2 Diabetes CohortNinna Hahn Tougaard, Alexandra Louise Møller, Pernille Falberg Rønn, et al.Pageof 66